文献速递乳腺乳腺X线MR

对比增强乳腺摄影用于乳房假体植入者新诊断乳腺癌的初步研究

Contrast-Enhanced Mammography for Newly Diagnosed Breast Cancer in Women With Breast Augmentation: Preliminary Findings.
PubMed 文献 · AJR Am J Roentgenol · 2021-03-17

在17例新诊断乳腺癌且接受对比增强乳腺摄影(CEM)与MRI的乳房假体植入女性中,两种方法对指数癌灶结果一致;CEM在6例中显示额外病灶并经MRI确认,其中2例为恶性,MRI未发现CEM未识别的额外癌灶。CEM可能适用于有MRI禁忌或MRI可及性有限的乳房假体植入女性。

要点

  • CEM与MRI对17例乳房假体植入者的指数癌灶均一致。
  • CEM在6/17例中显示额外病灶,MRI均确认,其中2例为恶性。
  • MRI未发现任何CEM未识别的额外癌灶。

关键影像表现/征象

  • CEM与MRI对17例的指数癌灶结果一致。
  • 6例中CEM显示额外病灶并经MRI确认:3例多灶、1例多中心、2例对侧。
  • 6例额外病灶中2例为恶性。
  • MRI未发现CEM未识别的额外癌灶。

临床应用与阅片要点

  • 对乳房假体植入且新诊断乳腺癌的女性,CEM与MRI对指数癌灶结果一致。
  • CEM可显示额外病灶并经MRI确认,其中部分为恶性。
  • CEM可能用于有MRI禁忌或MRI可及性有限的乳房假体植入女性。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

In 17 women with newly diagnosed breast cancer who underwent contrast-enhanced mammography (CEM) and MRI, both modalities were found to be concordant for the index cancer. In six of the 17 women, CEM showed an additional lesion that was confirmed by MRI. Of these six additional lesions, three were multifocal, one was multicentric, and two were contralateral; two of the six were malignant. MRI did not identify any additional cancers that were not identified on CEM. CEM may have a role in women with breast augmentation and either a contraindication or limited access to MRI.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Carnahan MB, Pockaj B, Pizzitola V, et al. Contrast-Enhanced Mammography for Newly Diagnosed Breast Cancer in Women With Breast Augmentation: Preliminary Findings. AJR Am J Roentgenol. 2021. PMID: 33728971. doi:10.2214/AJR.20.25341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。